Overview

The GMO Emerging Markets ex-China Fund seeks total return in excess of that of its benchmark, the MSCI Emerging Markets ex-China Index. GMO uses proprietary quantitative techniques and fundamental analysis to evaluate and select countries, sectors, and equity investments based on factors including, but not limited to, valuation, quality, patterns of price movement and volatility, macroeconomic factors, and ESG (environmental, social and governance) criteria. GMO expects the Fund will have a value bias relative to its benchmark.

Facts

Doc Table
Fund Inception Date October 18, 2021
Fund Total Assets as of 10/31/2021 $348mm USD
Benchmark MSCI Emerging Markets ex-China

Share Class VI

Inception Date October 18, 2021
Ticker Symbol GMAQX
CUSIP 36256V551
NAV as of 11/29/2021 19.24
Net Expense Ratio 1 0.67
Gross Expense Ratio 2 1.07
Minimum Investment Size $300mm in Fund / $750mm in GMO

1 Net Expense Ratio reflects the reduction of expenses from fee reimbursements. The fee reimbursements will continue until at least June 30, 2022. Elimination of this reimbursement will result in higher fees and lower performance.

2 Gross Expense Ratio is equal to the Funds Total Annual Operating Expenses set forth in the Funds most recent prospectus dated June 30, 2021.

Performance

Month-End as of October 31, 2021(USD, %)

Table Caption
MTD QTD YTD ITD
Emerging Markets ex-China Fund -0.75 -0.75 -0.75 -0.75
MSCI Emerging Markets ex-China -1.44 -1.44 -1.44 -1.44
  • Emerging Markets ex-China Fund
  • MSCI Emerging Markets ex-China

Inception Date: October 18, 2021

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Month-End as of October 31, 2021(USD, %)

Table Caption
MTD QTD YTD ITD
Emerging Markets ex-China Fund -0.73 -0.73 -0.73 -0.73
MSCI Emerging Markets ex-China -1.44 -1.44 -1.44 -1.44
  • Emerging Markets ex-China Fund
  • MSCI Emerging Markets ex-China

Inception Date: October 18, 2021

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Documents

Literature

Downloads

Performance Download
Portfolio Composition Download
Holdings Download
Download All Download

Commentary & Attribution

Attribution - Monthly Download
Attribution - YTD Download
Download All Download

Investor Information

NAVs and Distributions Download
Distribution Dates Download
Distribution Estimates Download
Tax-Related Distribution Information Download
Download All Download

Risks

Risks associated with investing in the Fund may include those as follows. (1) Market Risk - Equities: The market price of an equity may decline due to factors affecting the issuer or its industry or the economy and equity markets generally. Declines in stock market prices generally are likely to reduce the net asset value of the Fund's shares. (2) Non-U.S. Investment Risk: The market prices of many non-U.S. securities (particularly of companies tied economically to emerging countries) fluctuate more than those of U.S. securities. Many non-U.S. markets (particularly emerging markets), are less stable, smaller, less liquid, and less regulated than U.S. markets, and the cost of trading in those markets often is higher than it is in U.S. markets. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of non-U.S. issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries. (3) Currency Risk: Fluctuations in exchange rates can adversely affect the market value of the Fund's non-U.S. currency holdings and investments denominated in non-U.S. currencies. For a more complete discussion of these risks and others, please consult the Fund's prospectus.

Disclosures

An investor should consider the fund’s investment objectives, risks, charges and expenses before investing. This and other important information can be found in the fund’s prospectus. Read the prospectus carefully before investing. Please see prospectus above.

The GMO Trust funds are distributed in the United States by Funds Distributor LLC. GMO and Funds Distributor LLC are not affiliated.